Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A Phase 2a, randomized, double-blind, placebo-controlled, multiple ascending dose study in patients who are hospitalized with presumed pneumonia requiring suppl…
The aim of this study is to characterize patients in the Post-Intensive-Care-Syndrome (PICS) outpatient clinic based on routine data and to evaluate their treat…
To determine whether a strategy of adding venovenous ECMO to mechanical ventilation, as compared to mechanical ventilation alone, increases the number of intens…
Multicenter investigation featuring an open-label lead-in followed by a double blinded, randomized, placebo-controlled Phase 2/3 part to evaluate the safety and…
A double-blind, randomized, controlled, clinical trial to evaluate the efficacy and safety of MSC (mesenchymal stromal cells) intravenous administration in pati…